OK, not all biotech, then.
How about relatively better for biotech ?
Most don't yet have a drug on the market anyhow.... and this is surely worst news for the blockbuster drugs - on both counts worse for pharma, then.
Meantime, someone just put out a hitlist...
Associated Press
A List of the Best-Selling Drugs in U.S.
Thursday September 30, 2:55 pm ET
The top selling drugs in the United States in 2003, their annual sales, what it treats and its manufacturer. The 2003 data is the most recent audited figures available.
1. Lipitor, $6.8 billion, cholesterol, Pfizer Inc.
2. Zocor, $4.4 billion, cholesterol, Merck & Co.
3. Prevacid, $4.0 billion, heartburn, TAP Pharmaceutical Products Inc.
4. Procrit, $3.3 billion, anemia, Johnson & Johnson
5. Zyprexa, $3.2 billion, mental illness, Eli Lilly & Co.
6. Epogen, $3.1 billion, anemia, Amgen Inc.
7. Nexium, $3.1 billion, heartburn, Merck & Co.
8. Zoloft, $2.9 billion, depression, Pfizer Inc.
9. Celebrex, $2.6 billion, arthritis, Pfizer Inc.
10. Neurontin, $2.4 billion, epilepsy, Pfizer Inc.
11. Advair Diskus, $2.3 billion, asthma, GlaxoSmithKline PLC
12. Plavix, $2.2 billion, blood clots, Bristol-Myers Squibb Co.
13. Norvasc, $2.2 billion, high blood pressure, Pfizer Inc.
14. Effexor XR, $2.1 billion, depression, Wyeth
15. Pravachol, $2.0 billion, cholesterol, Bristol-Myers Squibb Co.
16. Risperdal, $2.0 billion, mental illness, Johnson & Johnson
17. Oxycontin, $1.9 billion, pain, Perdue Pharma
18. Fosamax, $1.8 billion, osteoporosis, Merck & Co.
19. Protonix, $1.8 billion, gastrointestinal reflux disease, Wyeth
20. Vioxx, $1.8 billion, arthritis, Merck & Co.
Source: IMS Health |
